REDWOOD CITY, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report first quarter 2016 financial results after market close on Monday, May 9, 2016.  Codexis management will hold an investment community conference call at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss financial results and provide a company update. 

Live Call:U.S.855 890 8665
 International720 634 2938
 Passcode1396086
   
Live Webcast:Codexis IR Website 
 The webcast will be archived for 30 days.
   
Replay:U.S.855 859 2056
 International404 537 3406
 Passcode1396086
 The replay will be available for 48 hours
  

About Codexis, Inc.
Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production. The company’s patent portfolio includes more than 850 patents and patent applications worldwide that cover its novel enzymes and proprietary methods for engineering new enzymes and their applications. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.

CONTACT:    
Investors
LHA
Jody Cain, 310 691 7100 
jcain@lhai.com

Media
That’s Nice
Guy Tiene, 212 366 4455
guy@thatsnice.com

Primary Logo